https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20200610-35
1. Scrip code : 532636
Name : IIFL FINANCE LIMITED
Subject : Intimation For Record Date For Transfer Of Debentures
In The Name Of IIFL Finance Limited From India Lnfoline Finance Limited Pursuant To Composite Scheme Of Arrangement. As informed earlier, that pursuant to the Composite Scheme of Arrangement as approved by Hon”ble National Company Law Tribunal vide its order dated March 7, 2019, India lnfoline Finance Limited got merged with IIFL Finance Limited w.e.f. March 30, 2020. Accordingly, all Non-Convertible Debentures (“NCDs”) issued by India lnfoline Finance Limited are required to be transferred in the name of IIFL Finance Limited. Further, in terms of Regulation 59 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has received in principal approval of the Stock Exchanges for the t ransfer of NCDs on April 9, 2020. In this regard, we hereby inform that the “Record Date” for the purpose of above mentioned transfer of NCDs issued to public will be June 19, 2020. The list of NCDs/ ISINs is enclosed. Kindly take the same on record and oblige.
2. Scrip code : 524648
Name : Indo Amines Ltd.
Subject : Announcement under Regulation 30 (LODR)-Scheme of Arrangement
This is to inform you that, pursuant to the Scheme of Amalgamation of Core Chemicals (Mumbai) Private Limited and Key Organics Private Limited with Indo Amines Limited and their respective Shareholders as approved by the National Company Law Tribunal, Mumbai Bench vide its order dated 24th April, 2020, 20,00,000 Equity Shares of Rs. 10/- each of the Company have been allotted to the Shareholders of Core Chemicals (Mumbai) Private Limited (Transferor Company No.1). We request you to kindly take the above information on record. Please find enclosed herewith detailed announcement.
3. Scrip code : 530313
Name : KIMIA BIOSCIENCES LIMITED
Subject : Bagging Of ‘Permission To Manufacture And Marketing Of ‘Obeticholic Acid’
We are pleased to inform that the Company has been granted ‘permission to Manufacturing and Marketing of New Active pharmaceutical Ingredient ‘Obeticholic Acid’ by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare, FDA Bhawan, New Delhi – 110002(India) Vide permission No. MF/SND/20/000140 dated 09-Jun-2020 in FORM CT-22 under Drugs & Cosmetics Acts & Rules thereunder. The said intimation has been given under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
4. Scrip code : 532555
Name : NTPC Limited
Subject : Update On Deferment Of Capacity Charges And Rebate To Discoms
In continuation of our letter dated 17.05.2020 regarding deferment of capacity charges and rebate to Distribution Companies (DISCOMs), it is informed that the NTPC Board of Directors in their meeting held on 09.06.2020 have approved: 1. Deferment of capacity charges of Rs. 2,064 crore to DISCOMs, to be payable without interest after the end of the lockdown period in three equal monthly instalments. 2. Rebate of Rs.1,363 crore on the capacity charges billed during the lock-down period to DISCOMs on account of COVID-19, in financial year 2020-21. The above amounts are provisional and may vary due to reconciliation with RPC data.
5. Scrip code : 539658
Name : TeamLease Services Limited
Subject : Announcement under Regulation 30 (LODR)-Updates on Acquisition
TeamLease : Acquisition of additional 24% stake in TeamLease E-Hire Private Limited (formerly known as Cassius Technologies Private Limited)
